Northwestern Events Calendar

Oct
20
2022

BMG Invited Speaker: Robert Roeder, PhD, The Rockefeller University, New York, NY

When: Thursday, October 20, 2022
10:00 AM - 11:00 AM Central

Where: Simpson Querrey Biomedical Research Center, Simpson Querrey Auditorium, 303 E. Superior Street, Chicago, IL 60611 map it

Audience: Faculty/Staff - Student - Post Docs/Docs - Graduate Students

Contact: Linda Mekhitarian Jackson   (312) 503-5229

Group: Biochemistry & Molecular Genetics Seminar Series

Category: Lectures & Meetings

Description:

The Department of Biochemistry & Molecular Genetics presents:

Robert Roeder, PhD

Arnold and Mabel Beckman Professor
Head of Laboratory of Biochecmistry and Molecular Biology
The Rockefeller University, New York, NY

Presentation:

"Mechanistic Studies of Transcriptional Regulation in Hematopoietic Malignancies"

Abstract:

Our laboratory is interested in biochemical mechanisms underlying transcriptional regulation by gene- and cell-specific DNA-binding factors in both normal (development, cell differentiation) and pathological (cancer) physiological processes -- and in particular the functions of transcriptional co-activators that include both chromatin modifying factors and other factors (e.g., Mediator and TAFs) that facilitate more direct communication between enhancer-bound regulatory factors and the general transcriptional machinery at the promoter. In the area of hematopoietic malignancies, we have major interests in the mechanism of action of the B cell-specific transcriptional co-activator OCA-B, which is critical for formation of germinal centers and implicated in GCB cell-derived lymphomas, and leukemic fusion proteins that include RUNX1-ETO, E2A-PBX1 and MLL-AF9/ENL. The presentation will describe recent studies that have identified new direct target genes and new mechanisms both for recruitment of these factors to target genes and for downstream effector functions.

Personal Statement:

Differential gene expression underlies key events in development, cell growth and differentiation, homeostasis, and pathologies such as cancer -- and is controlled primarily at the level of transcription. The execution and regulation of transcription is effected through a complex array of RNA polymerases, general initiation and elongation factors, gene- and cell-specific DNA-binding regulatory factors, and an increasingly complex array of cofactors that act either on the general transcription machinery or indirectly through chromosomal histone modifications. Over the past 50 years, I have made seminal contributions to both the discovery and an understanding of the structure, function, mechanism of action and regulation of many of these factors. These studies have emphasized the development and application of powerful cell-free transcription systems, reconstituted with purified factors and recombinant DNA or chromatin templates, in order to uniquely, and unequivocally, establish direct functions and mechanisms of action of specific factors on specific genes. At the same time, the biochemical studies have been complemented with cell-based and mouse genetic analyses, along with state of the art genomic and proteomic technologies, both to validate and to guide the in vitro studies. These complementary studies have led to significant new insights into transcriptional regulation in relation to physiological processes that include metabolism and homeostasis, cell growth and differentiation, and cancer -- through studies of nuclear hormone receptors (including PPARg and TRa in adipogenesis), tumor suppressor p53, B cell factors, and leukemic fusion proteins. Recent representative papers:

• C.-S. Chu, J. C. Hellmuth, R. Singh, H.-Y. Ying, L. Skrabanek, M. R. Teater, A. S. Doane, O. Elemento, A. M. Melnick, and R. G. Roeder*. Unique immune cell coactivators specify locus control region function and cell stage. Mol. Cell, 80:845-861.e10, 2020.  PMC7737631 

• K. Ito, M. Schneeberger, A. Gerber, M. Jishage, F. Marchildon, A. V. Maganti, P. Cohen, J.M. Friedman and R.G. Roeder. Critical roles of transcriptional co-activator MED1 in the formation and function of mouse adipose tissues. Genes Dev. 35:729-748, 2021.

• Y.-L. Lee, K. Ito, I.-H. Lin, W.-Y. Chen and R. G. Roeder. Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth. Proc. Natl. Acad. Sci. USA. 118 (6) e1922864118, 2021. 

• A. Wu, J. Zhi, T. Tian, A. Cihan, M. A. Cevher, Z. Liu, Y. David, T. W. Muir, R. G. Roeder* and M. Yu*. DOT1L Complex Regulates Transcriptional Initiation in Human Cells, Proc. Natl. Acad. Sci. USA. 118:e2106148118, 2021.  PMC8271641  *Co-corresponding authors.

Host: Dr. Shannon Lauberth, Associate Professor, Biochemistry and Molecular Genetics

 

 

Add to Calendar

Add Event To My Group:

Please sign-in